2025-11-06 - Analysis Report
Okay, here's an analysis of Schrodinger Inc. (SDGR) based on the information provided.

## SDGR (Schrodinger Inc) Analysis

**Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.

### 1. Performance vs. S&P 500 (VOO)

*   **SDGR Cumulative Return:** -50.71%
*   **VOO Cumulative Return:** 67.68%
*   **Absolute Divergence:** -120.0
*   **Divergence Range (max: 42.2, min: -120.9):** This indicates SDGR has significantly underperformed the S&P 500 over the period.
*   **Relative Divergence:** 0.6 -  The current divergence is near the bottom of its historical range relative to the S&P 500.

**Analysis of Provided Table:**

| Year       | CAGR   | MDD   | Alpha   | Beta | Cap(B) |
|------------|--------|-------|---------|------|--------|
| 2020-2022  | -70.0% | 78.2% | -76.0%  | 0.0  | 1.4    |
| 2021-2023  | -57.0% | 81.0% | -59.0%  | -0.0 | 2.6    |
| 2022-2024  | 6.0%  | 81.0% | -14.0%  | -0.0 | 1.4    |
| 2023-2025  | 1.0%  | 82.6% | -63.0%  | -0.0 | 1.5    |

*   **CAGR:** SDGR has delivered negative compounded annual growth for most periods, except 2022-2024.
*   **MDD:** High Maximum Drawdown (MDD) figures suggest significant volatility and downside risk.
*   **Alpha:** The consistently negative Alpha indicates SDGR has underperformed relative to its expected return based on its beta.
*   **Beta:** Beta values close to zero imply that SDGR's price is not highly correlated with the S&P 500.
*   **Cap(B):** The market capitalization is relatively small, making the stock more prone to volatility.

### 2. Recent Stock Price Movement

*   **Current Price:** 20.23
*   **Last Market Data:** Price 20.2, Previous Close 19.99, Change 1.05 (Slight increase in the last trading session)
*   **5-day Moving Average:** 20.69
*   **20-day Moving Average:** 20.70
*   **60-day Moving Average:** 19.93

The stock price is slightly below the 5-day and 20-day moving averages but above the 60-day moving average. This suggests a period of consolidation, but recent data indicates a rebound.

### 3. Technical Indicators and Market Risk

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended) - Signals a relatively safe investment environment.
*   **RSI:** 48.16 (Neutral) - Suggests neither overbought nor oversold conditions.
*   **PPO:** -0.62 (Negative) - A negative PPO indicates that the short-term moving average is below the long-term moving average, suggesting a potential downward trend.
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (47 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Delta_Previous_Relative_Divergence:** -1.7 (Negative) - Suggests short-term downward trend.
*   **Expected Return (%):** -6262.3% - Very low expected return compared to S&P 500.

**The small increase of 1.05 in 'change' from the previous close is not large enough to be considered as a significantly positive event.**

### 4. Recent News & Significant Events

*   **Earnings To Watch:** Upcoming Q3 2025 earnings report.
*   **Collaboration:** Copernic Catalysts collaboration on ammonia catalyst research.
*   **Valuation Assessment:** Articles discussing valuation and AI edge in drug discovery.
*   **AI Market Growth:** General news about AI in biotechnology market growth.

**Implication:** The news suggests that the market is focused on Schrodinger's earnings and its ability to leverage AI in drug discovery. The collaboration news is positive, but the focus on valuation also implies market concerns.

### 4-2. Analyst Opinions

*   **Consensus:** No clear consensus (no strong buy or sell recommendation).
*   **Target Price:** Average $27.00, High $33.00, Low $19.00. The target price range suggests potential upside from the current price, but a wide range indicates uncertainty.
*   **Recent Rating Changes:**  No recent rating changes provided

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출    |
|------------|-------|---------|
| 2025-08-06 | -0.59 | 0.05 B$ |
| 2025-05-07 | -0.82 | 0.06 B$ |
| 2024-11-12 | -0.52 | 0.04 B$ |
| 2024-07-31 | -0.74 | 0.05 B$ |
| 2025-08-06 | -0.74 | 0.05 B$ |

*   **EPS:** Consistently negative earnings per share (EPS).
*   **Revenue:** Relatively stable revenue, but low.

**Implication:** The company is not yet profitable, and low revenue is a concern.

### 6. Financial Information

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $0.05B  | 47.77%        |
| 2025-03-31   | $0.06B  | 52.26%        |
| 2024-12-31   | $0.09B  | 72.61%        |
| 2024-09-30   | $0.04B  | 50.24%        |
| 2024-06-30   | $0.05B  | 66.20%        |

| Quarter      | Equity  | ROE     |
|--------------|---------|---------|
| 2025-06-30   | $0.34B  | -12.59% |
| 2025-03-31   | $0.37B  | -16.01% |
| 2024-12-31   | $0.42B  | -9.54%  |
| 2024-09-30   | $0.45B  | -8.49%  |
| 2024-06-30   | $0.47B  | -11.40% |

*   **Revenue:** Fluctuating revenue, but generally low.
*   **Profit Margin:** High profit margins, but on a low revenue base.
*   **Equity:** Declining equity.
*   **ROE:** Negative Return on Equity (ROE), reflecting the company's unprofitability.

### 7. Overall Summary

Schrodinger Inc. (SDGR) has significantly underperformed the S&P 500. Its historical data shows negative CAGR and high MDD. The company is currently unprofitable, with negative EPS and ROE, although it maintains high profit margins on its generated revenue. Recent news focuses on its AI applications and upcoming earnings, but the market seems cautious about its valuation. Analyst target prices suggest potential upside, but the wide range indicates uncertainty. From a technical perspective, the MRI is high, but the PPO indicates a downward trend. The stock appears risky.
